AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $46,000 | -54.9% | 20,064 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $102,000 | -42.0% | 21,476 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $176,000 | +11.4% | 22,120 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $158,000 | -24.0% | 22,645 | -13.9% | 0.00% | 0.0% |
| Q1 2021 | $208,000 | +0.5% | 26,310 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $207,000 | +16.3% | 26,240 | +4.5% | 0.00% | 0.0% |
| Q3 2020 | $178,000 | -25.2% | 25,110 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $238,000 | +230.6% | 25,681 | +65.8% | 0.00% | – |
| Q1 2020 | $72,000 | -42.4% | 15,488 | -5.5% | 0.00% | – |
| Q4 2019 | $125,000 | -1.6% | 16,383 | -0.8% | 0.00% | -100.0% |
| Q3 2019 | $127,000 | +11.4% | 16,521 | -0.7% | 0.00% | – |
| Q2 2019 | $114,000 | +16.3% | 16,636 | +36.6% | 0.00% | – |
| Q1 2019 | $98,000 | +21.0% | 12,175 | +12.3% | 0.00% | – |
| Q4 2018 | $81,000 | -22.1% | 10,843 | +0.2% | 0.00% | – |
| Q3 2018 | $104,000 | -7.1% | 10,816 | +1.8% | 0.00% | – |
| Q2 2018 | $112,000 | – | 10,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
| Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
| Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
| Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
| Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
| Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
| Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
| Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
| Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |